Repaglinide
Chemical Name: 2-Ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid
Purity: ≥99%
Biological Activity
Repaglinide is a Kir6 (KATP) channel blocker that binds with high affinity for SUR1 when co-expressed with Kir6.2 (Kd = 0.42 nM). Antidiabetic glucose regulator with hypoglycaemic effect in vivo.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Hypoglycaemic effects of the novel antidiabetic agent repagl. in rats and dogs.
Mark and Grell
Br.J.Pharmacol., 1997;121:1597 -
Kir6.2-dependent high-affinity repagl. binding to β-cell KATP channels.
Hansen et al.
Br.J.Pharmacol., 2005;144:551
Product Datasheets
Reconstitution Calculator
Molarity Calculator
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Repaglinide
There are currently no reviews for this product. Be the first to review Repaglinide and earn rewards!
Have you used Repaglinide?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image